# Brightflow

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/brightflow

- Industry: Medical Devices & Equipment
- Headquarters: Paris, France
- Total disclosed funding: $21M
- Latest round: Series A (Sep 2, 2024)
- Investors on record: 5

## About

Founded in 2020 and based in Paris, France, Brightflow SAS, a.k.a. Brightflow, operates as a medical device company that focuses on developing percutaneous mechanical support devices for right ventricular failure that enable treatment without the need for open-heart surgery. In September 2024, Brightflow SAS raised EUR 16.5 million in a series A funding co-led by BNP Paribas Développement, Majycc eSanté Invest, and Vives, with participation from GO CAPITAL and Karista. As of September 2024, Sophie Humbert is the CEO of the company.

The company provides long-term mechanical assist devices to support RV failure without the need for open-heart surgery.

The company plans to use its proceeds from September 2024 funding to continue its research and development of right ventricular mechanical support devices.

## Funding rounds

- Series A, Sep 2, 2024, $18M — Karista, Go Capital, Vives, BNP Paribas Developpement, Majycc eSante Invest
- Seed, Jun 1, 2021, $2.4M — Karista, Go Capital

## Investors

- Karista (https://capitalatlas.ai/funds/karista) — Seed, Series A
- Go Capital — Seed, Series A
- Vives (https://capitalatlas.ai/funds/vives) — Series A
- BNP Paribas Developpement (https://capitalatlas.ai/funds/bnp-paribas-developpement) — Series A
- Majycc eSante Invest (https://capitalatlas.ai/funds/majycc-esante-invest) — Series A